The goal of the meeting is to further the understanding of lymphoma pathogenesis and accelerate new therapies by providing a forum for scientific exchange. The four-day meeting consists of didactic sessions, abstract presentations, and interactive workshops/panel discussions. The target audience for this meeting includes laboratory-based scientists, translational investigators, pharmaceutical scientists, and others interested in lymphoma science.
Event date: 2-5 August, 2018
Venue: Washington